JP2020534337A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534337A5 JP2020534337A5 JP2020516833A JP2020516833A JP2020534337A5 JP 2020534337 A5 JP2020534337 A5 JP 2020534337A5 JP 2020516833 A JP2020516833 A JP 2020516833A JP 2020516833 A JP2020516833 A JP 2020516833A JP 2020534337 A5 JP2020534337 A5 JP 2020534337A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- pharmaceutical composition
- composition according
- dbi
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17306229 | 2017-09-20 | ||
| EP17306229.0 | 2017-09-20 | ||
| PCT/EP2018/075286 WO2019057742A1 (en) | 2017-09-20 | 2018-09-19 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATION OF AUTOPHAGIA |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020534337A JP2020534337A (ja) | 2020-11-26 |
| JP2020534337A5 true JP2020534337A5 (https=) | 2021-08-05 |
| JP7330174B2 JP7330174B2 (ja) | 2023-08-21 |
Family
ID=60009555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516833A Active JP7330174B2 (ja) | 2017-09-20 | 2018-09-19 | オートファジーをモジュレーションするための方法及び医薬組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (5) | US20200268837A1 (https=) |
| EP (1) | EP3684471A1 (https=) |
| JP (1) | JP7330174B2 (https=) |
| CN (1) | CN111655340A (https=) |
| WO (1) | WO2019057742A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4013883A1 (en) * | 2019-08-16 | 2022-06-22 | Janssen Biotech, Inc. | Therapeutic immune cells with improved function and methods for making the same |
| CN118922206A (zh) * | 2022-02-08 | 2024-11-08 | 国家医疗保健研究所 | 乙酰辅酶a结合蛋白的中和赋予自噬依赖性器官保护 |
| EP4309733A1 (en) * | 2022-07-22 | 2024-01-24 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Neutralization of acyl-coa binding protein for the treatment of cardiac dysfunction |
| CN115990159B (zh) * | 2023-02-16 | 2024-05-17 | 中山大学 | 阿曲生坦或其药学上可接收的盐在制备治疗肌肉萎缩侧索硬化症产品中的应用 |
| EP4698185A1 (en) * | 2023-04-18 | 2026-02-25 | Osasuna Therapeutics SA | Methods and systems for improving anti-cancer therapies |
| WO2025134073A2 (en) * | 2023-12-22 | 2025-06-26 | Institut National de la Santé et de la Recherche Médicale | Methods and compositions for treating diseases or conditions induced by corticosteroids, synovial inflammation, and degenerative joint disease |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| ES2259800T3 (es) | 1990-06-11 | 2006-10-16 | Gilead Sciences, Inc. | Procedimientos de uso de ligandos de acido nucleico. |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| EP0690452A3 (en) | 1994-06-28 | 1999-01-07 | Advanced Micro Devices, Inc. | Electrically erasable memory and method of erasure |
| EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| EP1222277A2 (en) * | 1999-10-05 | 2002-07-17 | Curagen Corporation | Endozepine-like polypeptides and polynucleotides encoding same |
| US20060073141A1 (en) | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
| US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| CA2758189C (en) | 2009-04-10 | 2020-12-29 | Association Institut De Myologie | Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| WO2015049365A2 (en) * | 2013-10-03 | 2015-04-09 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof |
-
2018
- 2018-09-19 CN CN201880060882.7A patent/CN111655340A/zh active Pending
- 2018-09-19 JP JP2020516833A patent/JP7330174B2/ja active Active
- 2018-09-19 WO PCT/EP2018/075286 patent/WO2019057742A1/en not_active Ceased
- 2018-09-19 EP EP18773981.8A patent/EP3684471A1/en active Pending
- 2018-09-19 US US16/648,744 patent/US20200268837A1/en active Pending
-
2022
- 2022-09-26 US US17/935,261 patent/US11905330B1/en active Active
- 2022-09-26 US US17/935,255 patent/US20230142694A1/en active Pending
-
2024
- 2024-02-16 US US18/444,102 patent/US12343376B2/en active Active
-
2025
- 2025-05-28 US US19/221,186 patent/US20260097094A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020534337A5 (https=) | ||
| TWI775868B (zh) | 用於對ｈｂｖ產生免疫反應之類病毒粒子 | |
| Hong et al. | Hepatic stellate cells express functional CXCR4: Role in stromal cell–derived factor‐1α–mediated stellate cell activation | |
| KR101935088B1 (ko) | Ror1 암을 치료하고 전이를 저해하는데 이용을 위한 항체와 백신 | |
| JP6882782B2 (ja) | 遺伝子コードされた本質的に無秩序な送達用ステルスポリマーおよびその使用方法 | |
| US10538586B2 (en) | Compositions and methods for treating fatty tissue buildup | |
| JP6876732B2 (ja) | α−ＭＳＨのＣｌｐＢタンパク質模倣体を介した食欲の調節に及ぼす細菌の影響 | |
| CA2969635C (en) | Method for the treatment of idiopathic pulmonary fibrosis | |
| JP7330174B2 (ja) | オートファジーをモジュレーションするための方法及び医薬組成物 | |
| CN103261412A (zh) | 抗人ccr7 抗体、杂交瘤、核酸、载体、细胞、医药组合物和抗体固定化担载体 | |
| EP3854414A1 (en) | Anti-adrenomedullin (adm) binder for use in therapy or prevention of symptoms of illness | |
| CN105263964A (zh) | 抗-TNF-α/CXCL10双靶向抗体及其应用 | |
| JP2018512417A (ja) | グルカゴン受容体アンタゴニスト抗体を用いた肥満症および非アルコール性脂肪性肝疾患または非アルコール性脂肪性肝炎を治療するための方法 | |
| La Rocca et al. | Systemic vasculitis: one year in review 2022 | |
| US20150376281A1 (en) | Use of NKG2D Inhibitors for Treating Cardiovascular and Metabolic Diseases, Such as Type 2 Diabetes | |
| CN110891606A (zh) | 通过抑制α蛋白激酶1治疗炎症和相关疾病和病症的方法 | |
| CN108350069A (zh) | 针对il-23的多肽 | |
| JP2018104422A (ja) | 低体温改善剤 | |
| CN106279435A (zh) | 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用 | |
| US20240408207A1 (en) | Compositions and methods for treating cancer by targeting endothelial cells having upregulated expression of transmembrane molecules | |
| US11987645B2 (en) | Peptide for treating rheumatoid arthritis and use thereof | |
| EP4073113A1 (en) | Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction | |
| JP2021534109A (ja) | ヘパピティスｂウイルス複製およびヘパピティスｂウイルス表面抗原分泌の抑制方法 | |
| US20180028618A1 (en) | Compositions and methods for treating obesity and hyperphagia | |
| EP3892635A1 (en) | Anti-c-met agonist antibody and use thereof |